Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$86.5 - $128.27 $101,637 - $150,717
-1,175 Closed
0 $0
Q1 2022

May 05, 2022

BUY
$101.96 - $128.34 $44,862 - $56,469
440 Added 59.86%
1,175 $138,000
Q4 2021

Feb 08, 2022

SELL
$106.37 - $130.68 $116,900 - $143,617
-1,099 Reduced 59.92%
735 $95,000
Q3 2021

Oct 27, 2021

BUY
$102.91 - $122.75 $113,098 - $134,902
1,099 Added 149.52%
1,834 $207,000
Q4 2020

Jan 27, 2021

SELL
$71.69 - $91.23 $105,814 - $134,655
-1,476 Reduced 66.76%
735 $67,000
Q3 2020

Oct 26, 2020

BUY
$67.19 - $87.44 $23,382 - $30,429
348 Added 18.68%
2,211 $176,000
Q2 2020

Aug 04, 2020

BUY
$57.54 - $76.95 $72,903 - $97,495
1,267 Added 212.58%
1,863 $129,000
Q1 2020

Apr 09, 2020

BUY
$52.41 - $81.0 $681 - $1,053
13 Added 2.23%
596 $112,000
Q4 2019

Jan 06, 2020

BUY
$71.7 - $82.09 $17,064 - $19,537
238 Added 68.99%
583 $136,000
Q3 2019

Oct 16, 2019

BUY
$61.55 - $75.43 $12,556 - $15,387
204 Added 144.68%
345 $76,000
Q2 2019

Aug 05, 2019

SELL
$55.74 - $64.41 $18,617 - $21,512
-334 Reduced 70.32%
141 $0
Q4 2018

Jan 29, 2019

BUY
$46.41 - $56.94 $9,282 - $11,388
200 Added 72.73%
475 $73,000
Q3 2018

Oct 29, 2018

SELL
$45.7 - $58.03 $6,855 - $8,704
-150 Reduced 35.29%
275 $48,000
Q2 2018

Aug 10, 2018

SELL
$42.45 - $51.3 $18,041 - $21,802
-425 Reduced 50.0%
425 $61,000
Q1 2018

May 07, 2018

BUY
$37.19 - $47.45 $12,086 - $15,421
325 Added 61.9%
850 $119,000
Q3 2017

Nov 06, 2017

BUY
$36.29 - $38.83 $19,052 - $20,385
525
525 $57,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Simon Quick Advisors, LLC Portfolio

Follow Simon Quick Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simon Quick Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simon Quick Advisors, LLC with notifications on news.